NCT06429150 2026-04-24Frontline Combination CAR-T Cell Therapy for Multiple Myeloma or PlasmacytomaShenzhen Geno-Immune Medical InstitutePhase 1/2 Recruiting20 enrolled
NCT06435910 2026-04-24Engineered Dendritic Cell Vaccines for Multiple MyelomaShenzhen Geno-Immune Medical InstitutePhase 1 Recruiting10 enrolled